Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia

被引:14
|
作者
Lysaker, PH
Bell, MD
Bioty, SM
Zito, WS
机构
[1] INDIANA UNIV PURDUE UNIV,INDIANAPOLIS,IN 46202
[2] W HAVEN VET AFFAIRS MED CTR,NEW HAVEN,CT
[3] YALE UNIV,SCH MED,NEW HAVEN,CT
关键词
NONDEFICIT FORMS; SYNDROME SCALE; COCAINE ABUSE; DEFICIT; RELIABILITY;
D O I
10.1097/00005053-199701000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Research has not consistently indicated that negative symptoms in schizophrenia are temporally stable. One possible explanation for this is that stable negative symptoms are a characteristic of only some individuals with schizophrenia. The current study explored whether cognitive impairment and stimulant abuse history were associated with an-count of change in negative symptom level over a 1-year period. Results indicated that among 72 subjects with schizophrenia, performance on the Wisconsin Card Sorting Test and history of stimulant abuse significantly accounted for 18% of the variance in symptom variability after age, intelligence quotient, and initial symptom severity were controlled. As hypothesized, poorer performance on the Wisconsin Carding Sorting Test was associated with less symptom variability, whereas a more extensive stimulant abuse history was associated with greater variability. A discriminant function analysis was able to correctly classify 96% of subjects as having stable symptoms but only 30% as having unstable symptoms indicating a sensitive, but not specific, classification. This finding suggests that cognitive deficits may be a necessary but insufficient condition for temporal stability of negative symptoms and that negative symptoms in schizophrenia are a complex phenomenon best understood in the context of other features of illness and psychosocial variables.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Negative symptoms and cognitive impairment in schizophrenia
    Kukulska, D
    Parnowska, D
    Jarema, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S226 - S226
  • [2] Cognitive impairment in substance abuse
    Vik, PW
    Cellucci, T
    Jarchow, A
    Hedt, J
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 27 (01) : 97 - +
  • [3] CHARACTERIZATION OF THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA
    LOMBARDI, J
    HARVEY, PD
    LIEBMAN, M
    WHITE, L
    PARRELLA, M
    POWCHIK, P
    DAVIDSON, M
    BIOLOGICAL PSYCHIATRY, 1995, 37 (09) : 665 - 665
  • [4] Substance abuse and cognitive functioning in schizophrenia
    Addington, J
    Addington, D
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1997, 22 (02): : 99 - 104
  • [5] Reward dysfunction and negative symptoms in schizophrenia: Insights from the comorbidity with substance abuse
    Krystal, J. H.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 374 - 374
  • [6] Defeatist Beliefs as a Mediator of Cognitive Impairment, Negative Symptoms, and Functioning in Schizophrenia
    Grant, Paul M.
    Beck, Aaron T.
    SCHIZOPHRENIA BULLETIN, 2009, 35 (04) : 798 - 806
  • [7] The Role of Low Cognitive Effort and Negative Symptoms in Neuropsychological Impairment in Schizophrenia
    Strauss, Gregory P.
    Morra, Lindsay F.
    Sullivan, Sara K.
    Gold, James M.
    NEUROPSYCHOLOGY, 2015, 29 (02) : 282 - 291
  • [8] Relationships between symptoms of schizophrenia and substance abuse
    Brunette, MF
    Mueser, KT
    Xie, HY
    Drake, RE
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1997, 185 (01) : 13 - 20
  • [9] STABILITY OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    MICHAEL, A
    MATHAI, PJ
    CHATURVEDI, SK
    GOPINATH, PS
    BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 : 281 - 281
  • [10] Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia
    Sekine, Y
    Takei, N
    Suzuki, K
    Nakamura, K
    Tsuchiya, KJ
    Takebayashi, K
    Toulopoulou, T
    Mori, N
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 281 - 283